CNXU · Conexeu Sciences Inc.
$5.30
+0.68 (+14.72%)
At close · Sep 17
Going-concern doubt
— flagged Sep 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company's ability to raise additional funds and implement its business plan. These unaudited condensed interim financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Such adjustments could be material.”View the 10-Q filed Sep 14, 2026
Market Cap
$130.60M
Shares
28.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.62
Open$4.42
Day$4.42–4.70
Available close range$4.25–16.85
Avg vol 30d240K
Short int202K · 0.7% float · 1.0d
Short vol61%
DataMay 2026–Sep 2026
Filing10-Q · Sep 14
The closing range uses available history since May 21, 2026; less than a full year is stored.
Up next
filed Sep 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.97M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+91.3%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.7%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 17.7 · elevated
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−41%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
3%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.72% of float · ▲ +56.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — 13F breadth
Squeeze score
36
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
138%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
16.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−41%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.72% of float · ▲ +56.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — 13F breadth
Price context
position in its available closing range
Range low $4
Now $5 · 3%
Range high $17
vs 50-day avg -41%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNXU
this stock
Conexeu Sciences Inc.
|
$130.60M | — | — | — | 0.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.06B | +13.2% | +46.2% | 29.9 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.83B | +0.4% | +20.8% | 19.2 | 2.5% |
|
ARGX
Argenx SE
|
$60.93B | +17.1% | — | — | 2.0% |
|
CSLLY
Csl Ltd
|
$59.64B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
7
- % held
- 0.1%
- Net QoQ
- +25.4K sh
- Top holder
- UBS Group AG
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNXU | +3.6% | -53.8% | — | -35.7% | — |
| SPY | -1.1% | -1.8% | +14.8% | -1.7% | +10.6% |
| vs SPY | +4.7% | -52.0% | — | -34.0% | — |